Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/3/17 → 4/3/23 |
Funding
- Merck Sharp & Dohme Corporation (Prot #NU 16H07)
Prot #NU 16H07: Phase II Trial of Pembrolizumab in Combination with ICE Salvage Chemotherapy for Relapsed/Refractory Hodgkin Lymphoma
- Winter, Jane Norma (PD/PI)
Project: Research project